Dr Susanne Sheehy

Research

Susanne Sheehy is a physician training in Infectious Diseases & Microbiology in the Oxford deanery. She is currently working at the Jenner Institute as lead clinician on clinical trials of blood-stage malaria vaccines and is studying towards a Doctorate of Medicine in this area.

She has a particular interest in malaria challenge studies and has conducted both blood-stage and mosquito bite sporozoite challenge studies to date. She is the Lecturer in Clinical Medicine at St. Peter’s college Oxford.

Key Publications

Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-Stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors.
Sheehy SH, Duncan CJ, Elias SC, Collins KA, Ewer KJ, Spencer AJ, Williams AR, Halstead FD, Moretz SE, Miura K, Epp C, Dicks MDJ, Poulton ID, Lawrie AM, Berrie E, Moyle S, Long CA, Colloca S, Cortese R, Gilbert SC, Nicosia A, Hill AVS, Draper SJ. Mol Ther. 2011. In press

Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909. Duncan CJ, Sheehy SH, Ewer KJ, Douglas AD, Collins KA, Halstead FD, Elias SC, Lillie PJ, Rausch K, Aebig J, Miura K, Edwards NJ, Poulton ID, Hunt-Cooke A, Porter DW, Thompson FM, Rowland R, Draper SJ, Gilbert SC, Fay MP, Long CA, Zhu D, Wu Y, Martin LB, Anderson CF, Lawrie AM, Hill AV, Ellis RD.
PLoS One. 2011;6(7):e22271.

Malaria: severe, life-threatening. Sheehy SH, Angus BJ.
Clin Evid (Online). 2011 Mar 7;2011. pii: 0913.